Tasly Pharmaceutical Group Co., Ltd (600535.SS)
CNY 14.7
(0.75%)
CNY 14.7
(0.75%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.54 Billion CNY | -0.56% |
| 2022 | 8.59 Billion CNY | 8.06% |
| 2021 | 7.95 Billion CNY | -41.43% |
| 2020 | 13.57 Billion CNY | -28.54% |
| 2019 | 18.99 Billion CNY | 5.61% |
| 2018 | 17.98 Billion CNY | 11.78% |
| 2017 | 16.09 Billion CNY | 15.41% |
| 2016 | 13.94 Billion CNY | 5.43% |
| 2015 | 13.22 Billion CNY | 5.14% |
| 2014 | 12.58 Billion CNY | 13.25% |
| 2013 | 11.1 Billion CNY | 19.42% |
| 2012 | 9.3 Billion CNY | 41.58% |
| 2011 | 6.56 Billion CNY | 41.23% |
| 2010 | 4.65 Billion CNY | 16.5% |
| 2009 | 3.99 Billion CNY | 16.26% |
| 2008 | 3.43 Billion CNY | 22.87% |
| 2007 | 2.79 Billion CNY | 15.76% |
| 2006 | 2.41 Billion CNY | 64.7% |
| 2005 | 1.46 Billion CNY | 12.6% |
| 2004 | 1.3 Billion CNY | 23.31% |
| 2003 | 1.05 Billion CNY | 13.55% |
| 2002 | 929.78 Million CNY | 35.82% |
| 2001 | 684.55 Million CNY | 74.8% |
| 2000 | 391.61 Million CNY | 54.78% |
| 1999 | 253.01 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 2.09 Billion CNY | -8.57% |
| 2024 Q1 | 2.02 Billion CNY | -2.13% |
| 2024 Q2 | 2.28 Billion CNY | 13.09% |
| 2023 Q3 | 2.17 Billion CNY | -5.72% |
| 2023 Q1 | 2.08 Billion CNY | -16.54% |
| 2023 Q2 | 2.31 Billion CNY | 11.12% |
| 2023 FY | 8.54 Billion CNY | -0.56% |
| 2023 Q4 | 2.06 Billion CNY | -5.2% |
| 2022 Q2 | 2.14 Billion CNY | 14.56% |
| 2022 FY | 8.59 Billion CNY | 8.06% |
| 2022 Q4 | 2.49 Billion CNY | 19.26% |
| 2022 Q3 | 2.08 Billion CNY | -2.41% |
| 2022 Q1 | 1.86 Billion CNY | -14.32% |
| 2021 Q3 | 1.94 Billion CNY | -5.77% |
| 2021 Q2 | 2.06 Billion CNY | 16.92% |
| 2021 Q1 | 1.76 Billion CNY | -19.26% |
| 2021 FY | 7.95 Billion CNY | -41.43% |
| 2021 Q4 | 2.18 Billion CNY | 12.26% |
| 2020 Q1 | 3.95 Billion CNY | -19.43% |
| 2020 Q3 | 2.76 Billion CNY | -40.74% |
| 2020 Q4 | 2.18 Billion CNY | -21.06% |
| 2020 Q2 | 4.67 Billion CNY | 18.16% |
| 2020 FY | 13.57 Billion CNY | -28.54% |
| 2019 FY | 18.99 Billion CNY | 5.61% |
| 2019 Q3 | 4.67 Billion CNY | -3.52% |
| 2019 Q4 | 4.9 Billion CNY | 4.94% |
| 2019 Q1 | 4.57 Billion CNY | -7.93% |
| 2019 Q2 | 4.84 Billion CNY | 6.0% |
| 2018 Q4 | 4.96 Billion CNY | 9.15% |
| 2018 FY | 17.98 Billion CNY | 11.78% |
| 2018 Q3 | 4.54 Billion CNY | 0.56% |
| 2018 Q2 | 4.52 Billion CNY | 14.45% |
| 2018 Q1 | 3.95 Billion CNY | -19.87% |
| 2017 Q4 | 4.93 Billion CNY | 26.56% |
| 2017 FY | 16.09 Billion CNY | 15.41% |
| 2017 Q3 | 3.89 Billion CNY | -0.5% |
| 2017 Q1 | 3.34 Billion CNY | -22.78% |
| 2017 Q2 | 3.91 Billion CNY | 17.0% |
| 2016 Q1 | 3.14 Billion CNY | -18.19% |
| 2016 FY | 13.94 Billion CNY | 5.43% |
| 2016 Q4 | 4.33 Billion CNY | 34.99% |
| 2016 Q3 | 3.21 Billion CNY | -1.31% |
| 2016 Q2 | 3.25 Billion CNY | 3.48% |
| 2015 Q4 | 3.84 Billion CNY | 22.1% |
| 2015 Q1 | 3.07 Billion CNY | -8.41% |
| 2015 FY | 13.22 Billion CNY | 5.14% |
| 2015 Q2 | 3.15 Billion CNY | 2.55% |
| 2015 Q3 | 3.14 Billion CNY | -0.27% |
| 2014 Q3 | 3.1 Billion CNY | 0.22% |
| 2014 Q2 | 3.09 Billion CNY | 2.72% |
| 2014 FY | 12.58 Billion CNY | 13.25% |
| 2014 Q4 | 3.36 Billion CNY | 8.25% |
| 2014 Q1 | 3.01 Billion CNY | 0.06% |
| 2013 Q3 | 2.68 Billion CNY | 0.11% |
| 2013 Q1 | 2.72 Billion CNY | -4.04% |
| 2013 FY | 11.1 Billion CNY | 19.42% |
| 2013 Q4 | 3.01 Billion CNY | 12.19% |
| 2013 Q2 | 2.68 Billion CNY | -1.41% |
| 2012 FY | 9.3 Billion CNY | 41.58% |
| 2012 Q4 | 2.83 Billion CNY | 23.84% |
| 2012 Q2 | 2.04 Billion CNY | -3.97% |
| 2012 Q1 | 2.12 Billion CNY | 17.71% |
| 2012 Q3 | 2.29 Billion CNY | 12.06% |
| 2011 Q1 | 1.37 Billion CNY | 6.83% |
| 2011 FY | 6.56 Billion CNY | 41.23% |
| 2011 Q2 | 1.62 Billion CNY | 17.99% |
| 2011 Q4 | 1.8 Billion CNY | 2.32% |
| 2011 Q3 | 1.76 Billion CNY | 9.09% |
| 2010 Q2 | 1.15 Billion CNY | 16.06% |
| 2010 Q3 | 1.21 Billion CNY | 5.57% |
| 2010 Q4 | 1.28 Billion CNY | 5.52% |
| 2010 FY | 4.65 Billion CNY | 16.5% |
| 2010 Q1 | 994.18 Million CNY | -12.11% |
| 2009 Q3 | 1.02 Billion CNY | 3.47% |
| 2009 FY | 3.99 Billion CNY | 16.26% |
| 2009 Q4 | 1.13 Billion CNY | 10.39% |
| 2009 Q2 | 990.36 Million CNY | 17.01% |
| 2009 Q1 | 846.41 Million CNY | -15.54% |
| 2008 Q4 | 1 Billion CNY | 18.78% |
| 2008 Q1 | 756.06 Million CNY | -6.65% |
| 2008 FY | 3.43 Billion CNY | 22.87% |
| 2008 Q2 | 832.41 Million CNY | 10.1% |
| 2008 Q3 | 843.63 Million CNY | 1.35% |
| 2007 FY | 2.79 Billion CNY | 15.76% |
| 2007 Q2 | 657.79 Million CNY | 2.83% |
| 2007 Q1 | 639.69 Million CNY | -14.44% |
| 2007 Q3 | 687.5 Million CNY | 4.52% |
| 2007 Q4 | 809.91 Million CNY | 17.8% |
| 2006 Q3 | 531.93 Million CNY | -10.63% |
| 2006 Q4 | 747.69 Million CNY | 40.56% |
| 2006 Q1 | 539.53 Million CNY | 7.21% |
| 2006 FY | 2.41 Billion CNY | 64.7% |
| 2006 Q2 | 595.17 Million CNY | 10.31% |
| 2005 FY | 1.46 Billion CNY | 12.6% |
| 2005 Q1 | 219.95 Million CNY | -50.58% |
| 2005 Q4 | 503.24 Million CNY | 46.61% |
| 2005 Q3 | 343.26 Million CNY | -14.06% |
| 2005 Q2 | 399.4 Million CNY | 81.59% |
| 2004 Q1 | 197.22 Million CNY | -53.72% |
| 2004 Q3 | 323.98 Million CNY | -3.44% |
| 2004 Q4 | 445.1 Million CNY | 37.38% |
| 2004 FY | 1.3 Billion CNY | 23.31% |
| 2004 Q2 | 335.52 Million CNY | 70.12% |
| 2003 FY | 1.05 Billion CNY | 13.55% |
| 2003 Q4 | 426.15 Million CNY | 92.13% |
| 2003 Q3 | 221.8 Million CNY | 0.47% |
| 2003 Q1 | 187.03 Million CNY | -41.17% |
| 2003 Q2 | 220.76 Million CNY | 18.04% |
| 2002 Q1 | 140.39 Million CNY | 0.0% |
| 2002 Q2 | 224.75 Million CNY | 60.09% |
| 2002 FY | 929.78 Million CNY | 35.82% |
| 2002 Q3 | 246.7 Million CNY | 9.77% |
| 2002 Q4 | 317.93 Million CNY | 28.87% |
| 2001 FY | 684.55 Million CNY | 74.8% |
| 2000 FY | 391.61 Million CNY | 54.78% |
| 1999 FY | 253.01 Million CNY | 0.0% |